![Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.7b00109/asset/images/large/jm-2017-00109c_0010.jpeg)
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
![Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists](https://www.frontiersin.org/files/Articles/447554/fphar-10-00407-HTML/image_m/fphar-10-00407-g001.jpg)
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
![Positive allosteric modulation of endogenous delta opioid receptor signaling in the enteric nervous system is a potential treatment for gastrointestinal motility disorders | American Journal of Physiology-Gastrointestinal and Liver Physiology Positive allosteric modulation of endogenous delta opioid receptor signaling in the enteric nervous system is a potential treatment for gastrointestinal motility disorders | American Journal of Physiology-Gastrointestinal and Liver Physiology](https://journals.physiology.org/cms/10.1152/ajpgi.00297.2021/asset/images/medium/gi-00297-2021r01.png)
Positive allosteric modulation of endogenous delta opioid receptor signaling in the enteric nervous system is a potential treatment for gastrointestinal motility disorders | American Journal of Physiology-Gastrointestinal and Liver Physiology
![Identification of Dynorphins as Endogenous Ligands for an Opioid Receptor-like Orphan Receptor (∗) - Journal of Biological Chemistry Identification of Dynorphins as Endogenous Ligands for an Opioid Receptor-like Orphan Receptor (∗) - Journal of Biological Chemistry](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/b4a39ee8-35cb-4f3c-8dbe-c736b8241ba9/gr1.jpg)
Identification of Dynorphins as Endogenous Ligands for an Opioid Receptor-like Orphan Receptor (∗) - Journal of Biological Chemistry
![The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence - ScienceDirect The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006322319313794-gr1.jpg)
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence - ScienceDirect
![Five Decades of Research on Opioid Peptides: Current Knowledge and Unanswered Questions | Molecular Pharmacology Five Decades of Research on Opioid Peptides: Current Knowledge and Unanswered Questions | Molecular Pharmacology](https://molpharm.aspetjournals.org/content/molpharm/98/2/96/F1.large.jpg)
Five Decades of Research on Opioid Peptides: Current Knowledge and Unanswered Questions | Molecular Pharmacology
![Opioid Ligands Addressing Unconventional Binding Sites and More Than One Opioid Receptor Subtype - Drakopoulos - 2022 - ChemMedChem - Wiley Online Library Opioid Ligands Addressing Unconventional Binding Sites and More Than One Opioid Receptor Subtype - Drakopoulos - 2022 - ChemMedChem - Wiley Online Library](https://chemistry-europe.onlinelibrary.wiley.com/cms/asset/8d4cb99e-1f7e-4ddd-9090-4fdea1dc8071/cmdc202200169-toc-0001-m.jpg)
Opioid Ligands Addressing Unconventional Binding Sites and More Than One Opioid Receptor Subtype - Drakopoulos - 2022 - ChemMedChem - Wiley Online Library
![Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-021-88118-6/MediaObjects/41598_2021_88118_Fig7_HTML.png)
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
![Interaction between opioid receptor on keratinocytes and nerve endings... | Download Scientific Diagram Interaction between opioid receptor on keratinocytes and nerve endings... | Download Scientific Diagram](https://www.researchgate.net/publication/6486538/figure/fig4/AS:277786490097671@1443240868230/Interaction-between-opioid-receptor-on-keratinocytes-and-nerve-endings-and-relationship.png)
Interaction between opioid receptor on keratinocytes and nerve endings... | Download Scientific Diagram
![κ-Opioid Receptors within the Nucleus Accumbens Shell Mediate Pair Bond Maintenance | Journal of Neuroscience κ-Opioid Receptors within the Nucleus Accumbens Shell Mediate Pair Bond Maintenance | Journal of Neuroscience](https://www.jneurosci.org/content/jneuro/32/20/6771/F7.large.jpg)
κ-Opioid Receptors within the Nucleus Accumbens Shell Mediate Pair Bond Maintenance | Journal of Neuroscience
![Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience](https://pubs.acs.org/cms/10.1021/acschemneuro.9b00195/asset/images/large/cn-2019-00195v_0001.jpeg)
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
![Will peripherally restricted kappa‐opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential? - Albert‐Vartanian - 2016 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library Will peripherally restricted kappa‐opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential? - Albert‐Vartanian - 2016 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/72b7cca4-2c69-4c1d-9ca9-f017f875ba0b/jcpt12404-fig-0002-m.jpg)